Abstract: A scheduling method includes classifying, by a PC, terminals into delay-sensitive terminals and delay-insensitive terminals according to their traffic types; setting an initial value and a maximum value of a poll failure counter of each of the delay-sensitive terminals; polling each of the delay-sensitive terminals; determining whether there exists a delay-sensitive terminal of which a current value of the poll failure counter is less than the maximum value; and if there exists no delay-sensitive terminal of which the present value of the poll failure counter is less than the maximum value, sequentially polling the delay-sensitive terminals and the delay-insensitive terminals.

Abstract: A method for destroying harmful cells is provided, applicable in treating proliferative diseases. The cells are destroyed by a combined treatment with a chemiluminescent agent and with a ligand-photosensitizer conjugate. The chemiluminescent agent emits light on reacting with oxygen species present in situ, the conjugate binds to the cell through its ligand and is activated by the emitted light, thereby destroying the cell. The method is demonstrated on a conjugate of transferrin-hematoporphyrin, which destroys cancerous cells in the presence of luminol.

Abstract: The present disclosure generally pertains to systems and methods for protecting network resources from denial of service attacks. In one exemplary embodiment, a responder stores an access filter value used to determine whether an incoming message frame has been transmitted from an authorized user. In this regard, a user communication device includes logic for determining the access filter value stored at the responder and includes the access filter value in a message frame transmitted from the computer to the responder. The responder compares the received access filter value to the stored access filter value. If such values match or otherwise correspond, the responder authenticates the message frame. However, if such values do not match or otherwise correspond, the responder discards the message frame. Thus, the responder processes authenticated message frames and discards unauthenticated message frames thereby preventing denial of service attacks from malicious users.

Abstract: A combination for use in optical trapping is provided, comprising, in series: an adaptable reflective optical element for sculpting a laser beam to produce a sculpted beam; a beam splitter for splitting the sculpted beam into a first and a second sculpted beam; a micro lens array for dividing the first sculpted beam into an array of beamlets to produce a plurality of focal points; relay optics; and a focusing lens; and, in parallel: a wavefront curvature sensing device for accepting and analyzing the second sculpted beam, and reporting to a computer.

Abstract: A method for preparing titanium dioxide particles co-doped with nitrogen and fluorine includes the steps of: mixing boric acid with ammonium fluorotitanate in an aqueous medium to form ammonium oxotrifluorotitanate; liquid-phase depositing the ammonium oxotrifluorotitanate on a silicon-containing substrate; and thermo-treating the ammonium oxotrifluorotitanate on the silicon-containing substrate at a temperature ranging from 300 to 1000° C.

Abstract: Biomimetic polymer networks comprising a heteropolymer network having a cavity, the cavity having a selective affinity for a moiety, methods for making biomimetic polymer networks, and methods for using biomimetic polymer networks.

Abstract: The present invention relates to IgE-dependent histamine releasing factor (HRF) and HRF-binding peptides, more precisely, deletion forms of HRF which are able to be formed as dimers containing amino acid sequence represented by SEQ ID NO:3, genes encoding thereof and novel HRF-binding peptides having an activity of inhibiting HRF. The deletion forms of HRF which are able to be formed as dimers of the present invention induces intracellular secretion of histamine and IL-8, making an excellent candidate for a drug for inhibiting allergic reaction triggered by HRF and a kit for detecting HRF in serum of an allergy patient. In addition, novel HFR-binding peptides of the present invention bind to HRF to inhibit the actions of HFR, so they can be effectively used for the prevention and the treatment of allergic diseases of animals including asthma and rhinitis or malaria.

Abstract: A solid composite electrolyte membrane for use in a lithium battery is provided which exhibits a conductivity ranging from about 10?4 S cm?1 to about 10?3 S cm?1 at ambient temperature. The membrane is formed by providing a glass or glass-ceramic powder formed from a mixture of lithium carbonate, alumina, titanium dioxide, and ammonium dihydrogen phosphate. The powder is mixed with a conditioning agent and at least one solvent, followed by the addition of a binder and one or more plasticizers. The resulting slurry is cast into a tape which is then subjected to a binder burn-off and sintering process to form the membrane. The resulting membrane may be a glass-ceramic composite having a porosity ranging from 0 to 50%, or the membrane may be further infiltrated with a polymer to form a water-impermeable polymeric-ceramic composite membrane.

Abstract: A method for making/growing an array of carbon nanotubes includes the steps of: (a) providing a substrate; (b) forming a light absorption film made of a light absorption material on the substrate; (c) forming a catalyst film on the light absorption film; (d) introducing a mixture of a carrier gas and a carbon source gas by flowing the mixture over/across the catalyst film; (e) focusing a laser beam on the light absorption film to locally heat the catalyst to a predetermined/reaction temperature; and (f) growing an array of the carbon nanotubes from the substrate.

Abstract: Bridged graphite oxide material comprising graphite sheets bridged by at least one diamine bridging group. The bridged graphite oxide material may be incorporated in polymer composites or used in adsorption media.

Abstract: A vertical organic transistor and a method for fabricating the same are provided, wherein an emitter, a grid with openings and a collector are sequentially arranged above a substrate. Two organic semiconductor layers are interposed respectively between the emitter and the grid with openings and between the grid with openings and the collector. The channel length is simply decided by the thickness of the organic semiconductor layers. The collector current depends on the space-charge-limited current contributed by the potential difference between the emitter and the openings of the grid. And the grid voltage can thus effectively control the collector current. Further, the fabrication process of the vertical organic transistor of the present invention is simple and exempt from using the photolithographic process.

Abstract: Multi-hop wireless networks have benefits in coverage extension and throughput improvement. In this multi-hop wireless networks, multiple channels are available to improve system performance through concurrent transmission. In this invention, a multi-channel assignment method is described.

Abstract: A display device including a plurality of pixels is provided, each pixel includes: a light emitting element; first and second driving transistors connected between a driving voltage and the light emitting element and supplying a driving current to the light emitting element; a first switching transistor transmitting a data voltage to the first driving transistor; a second switching transistor transmitting a data voltage to the second driving transistor; a first inverter generating an inversion voltage having a polarity opposite the data voltage and applying the inversion voltage to the first driving transistor; and a second inverter generating an inversion voltage having a polarity opposite the data voltage and applying the inversion voltage to the second driving transistor.

Abstract: Based at least in part on an understanding of the mechanisms by which small RNAs (e.g., naturally-occurring miRNAs) mediate RNA silencing in plants, rules have been established for determining, for example, the degree of complementarity required between an RNAi-mediating agent and its target, i.e., whether mismatches are tolerated, the number of mismatches tolerated, the effect of the position of the mismatches, etc. Such rules are useful, in particular, in the design of improved RNAi-mediating agents which allow for more exact control of the efficacy of RNA silencing.

Abstract: The invention relates to isolated anti-microRNA molecules. In another embodiment, the invention relates to an isolated microRNA molecule. In yet another embodiment, the invention provides a method for inhibiting microRNP activity in a cell.

Abstract: This invention provides a method of treating a subject suffering from a dermatologic condition, including, inter alia, psoriasis, contact dermatitis, and seboreic dermatitis, the method includes the step of administering to a subject a compound comprising a lipid or phospholipid moiety bound to a physiologically acceptable monomer, dimer, oligomer, or polymer, and/or a pharmaceutically acceptable salt or a pharmaceutical product thereof, in an amount effective to treat the subject suffering from a dermatologic condition.

Abstract: Disclosed herein is the discovery that administration of the NRIF3 family of transcriptional coregulators (NRIF3 and related molecules) to breast cancer cells induce rapid and profound apoptosis (nearly 100% cell death within 24 h). A novel death domain (DD1) was mapped to a short 30 amino acid region common to all members of the NRIF3 family. Two other death domains (DD2 and DD3) were also found to have effective breast cancer killing activities. Mechanistic studies showed that DD1-induced apoptosis occurred through a novel caspase-2 mediated pathway that involved mitochondria membrane permeabilization but did not require other caspases. Interestingly, cytotoxicity of NRIF3 related molecules was cell-type specific, as they selectively killed breast cancer or related cells but not other examined cells of different origins, suggesting the presence in breast cancer cells of a specific death switch that can be selectively triggered by NRIF3 and related molecules.

Abstract: A method of producing biological products using bacteria with an inactivated ptsHI and wild type err and no added glucose transport activity and which consumes nearly all glucose in the media is described. The ?ptsHI bacteria produce large quantities of recombinant protein without producing significant amounts of acetate. The bacteria grow well on standard LB broth without additional supplementation.

Abstract: Compositions comprising nanoparticles (e.g., nanocrystals) of stishovite silica are described. Such nanoparticles may be made by (1) subjecting a mesoporous silica starting material (e.g., SBA-16 or KIT-6) to a pressure of less than about 20 GPa (e.g., about 12 GPa); (2) heating the mesoporous silica starting material while under pressure to an elevated temperature of less than about 1000° C. (e.g., a temperature of between about 300° C. and about 400° C.); and thereafter isolating the nanoparticles. The nanoparticles may be used in a work tool that is configured and adapted for cutting, drilling, abrading, polishing, machining, or grinding, among other uses.